• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.

作者信息

Guerrero Elisa, Johnson Douglas B, Bachelot Anne, Lebrun-Vignes Bénédicte, Moslehi Javid J, Salem Joe-Elie

机构信息

Sorbonne Université, INSERM CIC Paris-Est, AP-HP, ICAN, Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, Department of Pharmacology, F-75013 Paris, France; Department of Anesthesiology, Pontificial Xaverian University, San Ignacio University Hospital, Bogotá, Colombia.

Departments of Medicine, Cardio-oncology Program, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Eur J Cancer. 2019 May;113:10-13. doi: 10.1016/j.ejca.2019.03.002. Epub 2019 Apr 4.

DOI:10.1016/j.ejca.2019.03.002
PMID:30954881
Abstract
摘要

相似文献

1
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.免疫检查点抑制剂相关垂体炎——世界卫生组织药物不良反应数据库报告分析
Eur J Cancer. 2019 May;113:10-13. doi: 10.1016/j.ejca.2019.03.002. Epub 2019 Apr 4.
2
Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors.免疫检查点抑制剂相关致命性肝炎报告增多。
Eur J Cancer. 2019 Dec;123:112-115. doi: 10.1016/j.ejca.2019.09.022. Epub 2019 Nov 1.
3
[Immune checkpoint inhibitors and endocrinological side effects].[免疫检查点抑制剂与内分泌副作用]
Ugeskr Laeger. 2017 Dec 4;179(49).
4
A decade of immune-checkpoint inhibitors in cancer therapy.免疫检查点抑制剂在癌症治疗中的十年。
Nat Commun. 2020 Jul 30;11(1):3801. doi: 10.1038/s41467-020-17670-y.
5
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.使用免疫检查点抑制剂的癌症免疫疗法诱导的肝损伤的特征。
J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.
6
Hematologic Complications of Immune Checkpoint Inhibitors.免疫检查点抑制剂的血液学并发症。
Oncologist. 2019 May;24(5):584-588. doi: 10.1634/theoncologist.2018-0574. Epub 2019 Feb 28.
7
Checkpoint blockade after kidney transplantation.肾移植后的检查点阻断
Eur J Cancer. 2018 Jun;96:111-114. doi: 10.1016/j.ejca.2018.03.019. Epub 2018 Apr 26.
8
Checkpoint Inhibitor-Induced Colitis.免疫检查点抑制剂相关性结肠炎
Am J Gastroenterol. 2020 Feb;115(2):202-210. doi: 10.14309/ajg.0000000000000497.
9
Checkpoint Inhibitor-Associated Hypophysitis.检查点抑制剂相关垂体炎
J Gen Intern Med. 2018 Jan;33(1):125-127. doi: 10.1007/s11606-017-4135-6. Epub 2017 Aug 2.
10
Cardiorenal complications of immune checkpoint inhibitors.免疫检查点抑制剂的心脏肾脏并发症。
Nat Rev Nephrol. 2018 Sep;14(9):571-588. doi: 10.1038/s41581-018-0035-1.

引用本文的文献

1
Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial.新辅助化疗和免疫治疗局部晚期胃和胃食管结合部腺癌的两年结果和生物标志物分析：来自 II 期武汉 UHGI001 试验的结果
Ann Surg Oncol. 2024 Nov;31(12):8157-8169. doi: 10.1245/s10434-024-16041-x. Epub 2024 Aug 17.
2
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.接受内分泌治疗和CDK4/6抑制剂治疗的乳腺癌女性患者的神经认知障碍：一项使用世界卫生组织数据库的药物警戒研究。
Front Pharmacol. 2023 Oct 20;14:1278682. doi: 10.3389/fphar.2023.1278682. eCollection 2023.
3
Three cases of immune-related hypopituitarism after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.三例肝癌患者在接受阿替利珠单抗联合贝伐珠单抗治疗后出现免疫相关性垂体功能减退症。
Clin J Gastroenterol. 2023 Jun;16(3):422-431. doi: 10.1007/s12328-023-01775-0. Epub 2023 Feb 23.
4
A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization.一项使用世界卫生组织 VigiBase 数据研究帕瑞昔布钠相关不良事件的区域性差异的研究。
Sci Rep. 2022 Dec 13;12(1):21568. doi: 10.1038/s41598-022-26211-0.
5
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis.接受免疫检查点抑制剂治疗的无骨转移患者骨转换标志物的变化：一项探索性分析。
J Bone Oncol. 2022 Oct 28;37:100459. doi: 10.1016/j.jbo.2022.100459. eCollection 2022 Dec.
6
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists.免疫检查点抑制剂治疗期间常规筛查中枢和原发性肾上腺功能不全：肿瘤学家的内分泌学视角。
Curr Oncol. 2022 Jul 2;29(7):4665-4677. doi: 10.3390/curroncol29070370.
7
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.免疫检查点抑制剂诱导的垂体炎及垂体功能丧失模式。
Front Oncol. 2022 Mar 8;12:836859. doi: 10.3389/fonc.2022.836859. eCollection 2022.
8
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.癌症免疫治疗学会（SITC）免疫检查点抑制剂相关不良反应临床实践指南。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002435.
9
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis.骨骨折作为一种新型免疫相关不良事件与免疫检查点抑制剂：病例系列和大规模药物警戒分析。
Int J Cancer. 2021 Aug 1;149(3):675-683. doi: 10.1002/ijc.33592. Epub 2021 May 4.
10
Immune Checkpoint Inhibitors and Neurotoxicity.免疫检查点抑制剂和神经毒性。
Curr Neuropharmacol. 2021;19(8):1246-1263. doi: 10.2174/1570159X19666201230151224.